Thursday, August 14, 2025

Predictmedix AI Launches Health Stations for US Market

Related stories

AI Agent Orchestration Explained: What It Is and Why It Matters

For years, we've marveled at individual AI agents. They...

Advarra Launches Braid™ to Enhance Clinical Trials with AI

Powered by the industry's largest set of digitized protocols...

Qubrid AI Launches 2-Step No-Code Multimodal RAG Service

Qubrid AI, a leader in high-performance GPU Cloud solutions,...

SiMa.ai Unveils Next-Gen Platform for Physical AI Production

Modalix™ in Production, Now Shipping SoM Pin-Compatible with leading...

Squint Secures $40M Series B to Advance Agentic Manufacturing

Squint, the leading Manufacturing Intelligence Platform, today announced it...
spot_imgspot_img

Predictmedix AI Inc., an innovative provider of AI-powered health screening solutions, is pleased to announce that it is launching its enhanced Smart Health AI Stations across the United States, positioning itself to capitalize on the rapidly expanding population health management market.

This strategic launch, in partnership with Manchester Marketing Group Inc., introduces advanced AI-powered health assessments featuring real-time vitals screening and substance induced impairment detection. Ten units are under consideration for potential showcasing to corporate and government entities nationwide in the USA. Manchester Marketing Group Inc. is based out of the USA and is working with partners for the North American, Central American and South American Market along with the Caribbean.

The Smart Health AI Station provides instant, non-contact health screenings using AI technology to detect potential health risks and promote safer environments. By delivering data-driven insights, Predictmedix AI facilitates proactive health management, shifting from reactive to preventative care. The company’s extensive health-related dataset is a cornerstone of its AI-driven solutions.

Market Opportunity: The population health management market, valued at USD 32.94 billion in 2023, is projected to surge to USD 126.16 billion by 2032, exhibiting a CAGR of 16.6%. North America holds a dominant 64.81% market share.

Also Read: CliniComp Unveils Intrinsic AI™ for Healthcare IT Revolution

“The US launch of our Smart Health AI Stations marks an important step in our mission to advance proactive health management,” stated Dr. Rahul Kushwah, COO of Predictmedix AI. “Through our partnership with Manchester Marketing Group Inc., we look forward to identifying opportunities to provide organizations with the tools they need to prioritize health, safety, and well-being. Our comprehensive data and experience position us to offer valuable health management solutions in the US market.”

James Cooke, Marketing Director for Manchester Marketing, emphasized, “We’re witnessing a paradigm shift in health management, and Predictmedix AI is at the forefront. The Smart Health AI Stations offer tangible, immediate benefits, and we’re seeing exceptional interest across sectors. Manchester Marketing Group is also pleased to also announce a business relationship with Dr. Aftab Ahmed and his network of 4,000 physicians throughout Pakistan and Dubai along with Dr. Harriette Kamendi’s program in Sub Sahara Africa. The units will be used for showcasing which will allow potential clients to experience firsthand the transformative power of this technology.”

Key Applications:

  • Workplace Wellness: Proactive health screening and data-driven wellness programs.
  • Healthcare Screening: Enhanced patient and visitor screening for infection control and safety.
  • Public Safety: Health management for large crowds at venues and events.
  • Education: Improved student and staff wellness in educational institutions.
  • Government: Ongoing health management in public buildings.

Source: Businesswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img